Riskpilot← Back to searchSign inGet full accessVinterhälsa AB
ABActiveOrg 5567023550Slammermora 410Medical specialists activities · NACE 8622Est. 20060 employees
Revenue 2025
SEK 3,2M
+1% vs 2024
EBITDA margin
26.2%
-4% vs 2024
Equity ratio
53.6%
Financial strength
Net profit 2025
SEK 637K
-1% vs 2024
| Revenue | SEK 3,2M | +1% |
| EBITDA | SEK 847K | -4% |
| Net profit | SEK 637K | -1% |
| Total assets | SEK 1,9M | -3% |
| Equity | SEK 1M | -1% |
| Employees | 0 | — |
Legal name
Vinterhälsa AB
Org number
5567023550
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 april 2006
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva läkartjänster samt därmed förenlig verksamhet. Vidare skall bolaget bedriva fastighetsförvaltning och konsultverksamhet mot handel och friskvård samt handel med värdepapper och därmed förenlig verksamhet.
Address
Slammermora 410
Phone
+46980319005
Email
mats@vinterhalsa.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 526 | 3 391 | 2 656 | 3 203 | 3 237 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 021 | 1 086 | 740 | 880 | 847 |
| Depreciation & amort. | −0 | −12 | −23 | −23 | −7 |
| EBIT | 1 021 | 1 074 | 717 | 857 | 840 |
| Net financials | −12 | −27 | −39 | −41 | −29 |
| Profit before tax | 1 009 | 1 029 | 696 | 817 | 811 |
| Tax | −216 | −218 | −150 | −175 | −174 |
| Net profit | 793 | 811 | 546 | 642 | 637 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 030 | 2 277 | 2 184 | 1 962 | 1 907 |
| Equity | 1 187 | 1 198 | 944 | 1 036 | 1 022 |
| Long-term debt | 586 | 708 | 601 | 657 | 583 |
| Short-term debt | 257 | 353 | 639 | 269 | 302 |
| Total debt | 843 | 1 061 | 1 240 | 926 | 885 |
EBITDA margin
26.2%
This company
15.8%
Market median
+66% vs market
20212025
Equity ratio
53.6%
This company
38.2%
Market median
+40% vs market
20212025
Return on equity
62.3%
This company
18.4%
Market median
+239% vs market
20212025
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
20212025
Asset turnover
1.70×
This company
1.12×
Market median
+52% vs market
20212025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MÅ Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vinterhälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Åke Lejerbäck | Chief Executive Officer | 0 companies |
| Mats Oscar August Lejerbäck Wolf | Deputy Board Member | 0 companies |